Topics

Latest "Impact Cryotherapy, Inc." News Stories - Page: 2

04:13 EDT 20th September 2019 | BioPortfolio

Here are the most relevant search results for "Impact Cryotherapy, Inc." found in our extensive news archives from over 250 global news sources.

More Information about Impact Cryotherapy, Inc. on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Impact Cryotherapy, Inc. for you to read. Along with our medical data and news we also list Impact Cryotherapy, Inc. Clinical Trials, which are updated daily. BioPortfolio also has a large database of Impact Cryotherapy, Inc. Companies for you to search.

Showing "Impact Cryotherapy" News Articles 26–50 of 3,900+

Wednesday 18th September 2019

The impact of fluid balance on outcomes in premature neonates: a report from the AWAKEN study group


C-Section Babies Are Missing Key Microbes

(Nature) – How a baby is born has a profound impact on their microbiome — the community of microbes that colonize the body. That’s the finding of the largest ever study of the newborn microbiome, which offers the strongest evidence … Read More

Covalon Announces Closing of Non-Brokered Private Placement

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced that, further to its press release dated September 6, 2019, it has completed a non-brokered private placement offering comprised of approximately 2,750,000 units (each, a “Unit”) of the Corporation at a price of $2.00 per Unit for aggregate gross ...


When it comes to #prostatecancer, age may impact your risk of diagnosis. In what age range do you think the most frequent prostate #cancer diagnoses occur? #ProstateCancerAwarenessMonth

When it comes to #prostatecancer, age may impact your risk of diagnosis. In what age range do you think the most frequent prostate #cancer diagnoses occur? #ProstateCancerAwarenessMonth

Stimwave Launches Post-Market Peripheral Neuropathy Pain Relief Randomized Controlled Trial for Pain Awareness Month

Treating painful small fiber peripheral neuropathy with wireless electroceutical therapy Stimwave Technologies, the leading innovator of wireless medical device bioelectronic technology, in honor of September Pain Awareness Month, today announces the launch of a new randomized clinical trial treating painful peripheral neuropathy, the “SMOOTH” study. Painful peripheral neuropathy resulting...

Rodrigo Bianchi Appointed as New LimaCorporate Advisory Board Member

SAN DANIELE DEL FRIULI, Italy, Sept. 18, 2019 /PRNewswire/ -- LimaCorporate is pleased to announce that Rodrigo Bianchi will join the LimaCorporate Advisory Board. Rodrigo Bianchi is a Senior Global Executive in the Medical Device Industry with over 30 years of experience in some of the most important Orthopedic companies. Recently, he served as President International...

Hearing Aid Devices Device Pipeline Study Analysis of Devices under Development, Companies, Developments and Outlook [Published by VPA Research] Prices from USD $1799

Global Hearing Aid Devices market is one of the largely focused segments of medical devices worldwide. The global Hearing Aid Devices industry is estimated to be around $7 billion in 2019.The 2019 Hearing Aid Devices pipeline is characterized by presence of 6 companies, actively assessing their devices. In particular, 3 companies are assessing their products in clinical phase. Currently, iHear Med...

CORRECTING and REPLACING CDISC Publishes First Standard Using Traditional Chinese Medicine

Please replace the release with the following corrected version due to multiple revisions in the third paragraph. The corrected release reads: CDISC PUBLISHES FIRST STANDARD USING TRADITIONAL CHINESE MEDICINE CDISC is pleased to announce the first release of a global Therapeutic Area Standard using Traditional Chinese Medicine. Specifically, the standard describes how to use

TEAMFund Closes $30M Impact Fund to Invest in Medical Tech Startups Improving Patient Access in Low-Resource Settings

TEAMFund (“Transforming Equity and Access for MedTech”) closes $30M inaugural fund to invest in medical tech startups that improve patient access in low-resource settings. TEAMFund invests in commercial-stage companies addressing non-communicable diseases in low-resource settings, with an initial geographic focus in India and Sub- Saharan Africa. TEAMFund has a 10-year horizon and expe...

Living with #ChronicPain can be devastating. Even getting out of bed can be difficult. It can interfere with your daily activities, work, impact your mood and even prevent you from sleeping. #PAM2019 #PainAwarenessMonth #LetsTalkAboutPainpic.twitter.com/

Living with #ChronicPain can be devastating. Even getting out of bed can be difficult. It can interfere with your daily activities, work, impact your mood and even prevent you from sleeping. #PAM2019 #PainAwarenessMonth #LetsTalkAboutPain pic.twitter.com/C6QoLM8ElC

Early life experiences underlie chronic obesity and binge-eating

A new study on the cognitive and emotional functioning of people with a high body mass index (BMI), which was published in the journal Heliyon shows that early life experiences can create a deep impact on future eating patterns and dietary habits leading to obesity or overweight.

Theo Chocolate unveils revamped look

Theo Chocolate u

CDISC Publishes First Standard Using Traditional Chinese Medicine

CDISC is pleased to announce the first release of a global Therapeutic Area Standard using Traditional Chinese Medicine. Specifically, the standard describes how to use CDISC standards to represent data pertaining to coronary artery disease for the treatment of angina. Released in the form of a User Guide for data manager

Study quantifies impact of NIH-sponsored trials on clinical cancer care

Researchers found trials add value regardless of whether findings were positive or negative.

bluebird bio Presents Updated Data from Phase 2/3 Clinical Study of Lenti-D™ Gene Therapy for Cerebral Adrenoleukodystrophy (CALD) at the 13th European Pediatric Neurology Society (EPNS) Congress

Long-Term Follow-up Data Show That the 88% of Patients Treated in the Starbeam Study (ALD-102) Were Free of Major Functional Disabilities (MFDs) at Two Years, and Continued to Remain MFD-Free at up to Five Years of Follow-up bluebird bio, Inc. (Nasdaq: BLUE) today announced updated results from the clinical development program for its investigational Lenti-D™ gene therapy in patients with cere...

INVENT.us Wins the Technology Disruptor Award in the 2019 wealthmanagement.com Industry Awards Program

Cloud-native technology platform recognized for its tremendous impact in transforming the wealth management technology industry SEATTLE (PRWEB) September 18, 2019 INVENT.us, an innovative software development consulting firm announced today that it has been recognized as the winner in the Technology Disruptors category in the prestigious 2019 wealthmanagement.com Industry Awards Program. INVENT...

Addressing Evidence Development Requirements for Improved Market Access of Orphan Disease Therapies, Upcoming Webinar Hosted by Xtalks

Globally, there is increasing demand for an evidence-based approach toward pricing and reimbursement for drug and gene therapies used to treat orphan diseases. However, Health Technology Assessments (HTAs) face complex submissions with limited data, which can set back their progress in drug development. In this free webinar, the featured speakers will discuss current challenges with data capture a...

Data Standards for eCOA in Clinical Trials, Upcoming Webinar Hosted by Xtalks

Collecting data in a standardized way is the next step to reduce messy, time-wasting efforts that can negatively impact patient safety, development timelines and resource utilization. This is especially important given the rapid proliferation of eClinical technologies. In this free webinar, hear about Clinical Data Interchange Standards Consortium (CDISC) standards across data collection, tabulati...

PTP Achieves Amazon Web Services (AWS) Life Sciences Competency

Pinnacle Technology Partners, Inc. (PTP), a born-in-the-cloud consulting and services firm, today announced it has been recognized by Amazon Web Services (AWS) as an AWS Life Sciences Competency Partner in the AWS Partner Network (APN). The AWS Life Sciences Competency distinction is who have demonstrated technical proficiency and proven customer success in building and managing Life Science solut...

Interactions between bacteria and parasites

A team has completed the first study of the effects of a simultaneous infection with blood flukes (schistosomes) and the bacterium Helicobacter pylori -- a fairly common occurrence in some parts of the world. They identified a complex interaction which resulted -- among other effects -- in a weakening of the adverse impact of the pathogens acting individually.

Comfort Your V Naturally with Heating and Cooling ‘Private Packs’

Designed to Provide Vaginal Relief, Private Packs is Disrupting the $50 Billion-Dollar Femtech Market BROOKLYN, N.Y. (PRWEB) September 18, 2019 Private Packs, an emerging women’s wellness company announces the launch of a set of natural, non-invasive heating and cooling pads used to soothe and comfort vulvas from myriad medical and beauty issues, or anytime a woman wants extra care of her vulva...

TEAMFund closes $30 million impact fund

TEAMFund -- a novel hybrid organization combining a non-profit with a for-profit fund investing in medical technology compani

Factors Predicting Persistence of Biologic Drugs in Psoriasis

Biologics for psoriasis often lose effectiveness over the long-term, resulting in discontinuation of therapy. What factors and comorbidities might impact drug persistence? The British Journal of Dermatology

The Effect of Smoking on Sternal Scar Healing

Could smoking affect the healing of sternal scars and impact the risk for hypertrophic scarring? Wounds

EnChroma Unveils New Kid’s Trial Kit and Color Blind Test for Kids

– Experience New Kid-Friendly Color Blindness Test and Unique, 8-Foot Color Blindness Simulator at Vision Expo West – At Vision Expo West, booth #19077, EnChroma, Inc. – creators of the only eyewear for color blindness backed by science – today announced the EnChroma® Kid’s Kit and a new kid-friendly color blind test for more easily testing children ages 5+ for color blindness. Scie


Quick Search

News Quicklinks